Our Strategy


We invest in Iran and Iran related biotechnology and pharmaceutical companies with exceptional technologies or product opportunities based on strong scientific rationale and commercial potential.

  1. Our key asset is a unique team of nearly 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support.
  2. We provide our portfolio companies with the necessary resources for long-term sustainable growth. We provide them with access to network, executive talent, strategic, operational, and business development resources.
  3. This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Iran’s Biotech industry which increases investment opportunities.
افزودن ماژول جدید